1st Quarter - Report

CHILDREN'S HEALTHCARE OF ATLANTA for CHILDREN'S HEALTHCARE OF ATLANTA

Firm
Client
Income
—
Expenses
$128,486
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medicaid program reforms, including telemedicine Section 340B Drug Pricing Program Sickle Cell Disease research funding generally Drug pricing reforms generally Reauthorization of Children's Hospital Graduate Medical Education program Mental and behavioral health legislation generally Children's Health Insurance Program (CHIP), regarding continuous eligibility

LobbyistCovered position, as disclosed
JAMILA POPE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Autism research programs and autism intervention programs generally Department of Health and Human Services programs regarding autism and sickle cell disease research Fiscal Year 2024 Department of Health and Human Services appropriations regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, sickle cell disease research, Advanced Research Projects Agency-Health, and other programs related to pediatric health care

LobbyistCovered position, as disclosed
JAMILA POPE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.